Skip to content
Biodatica
Start free

GORDON RESEARCH CONFERENCES

East Greenwich, RI

Oncologygene editingGrant-only
Compare Sign in to watch

What changed

NIH R01 · $0.8M · Mechanistic and Functional Evaluation of a Model of Cerebral Small Vessel Disease

2mo agoGrant renewalMay 18, 2026Source filing (opens the source filing in a new tab)

Momentum

70no change

Momentum 70 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

15,461 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    U01 · $2.5M · non-dilutive

    May 1, 2026

    MASSACHUSETTS GENERAL HOSPITAL · PI MUSOLINO, PATRICIA L · NINDS · award ends Apr 30, 2029 · Targeted Gene Repair Therapy for Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS) Caused by ACTA2 R179H Mutation

    NIH RePORTER · NIH RePORTER 11348523 (opens the source filing in a new tab)

  2. Grant

    R13 · $25k · non-dilutive

    Jul 1, 2025

    GORDON RESEARCH CONFERENCES · PI GOULD, DOUGLAS · NIAMS · award ends Jun 30, 2026 · 2025 Collagen Gordon Research Conference and Gordon Research Seminar

    NIH RePORTER · NIH RePORTER 11240679 (opens the source filing in a new tab)

  3. Grant

    R01 · $711k · non-dilutive

    Jun 1, 2025

    UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOULD, DOUGLAS · NEI · award ends May 31, 2029 · Genetically testing mechanisms of ocular development and disease

    NIH RePORTER · NIH RePORTER 11050226 (opens the source filing in a new tab)

  4. Grant

    R01 · $793k · non-dilutive

    May 1, 2025

    UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOULD, DOUGLAS · NINDS · award ends Apr 30, 2030 · Mechanistic and Functional Evaluation of a Model of Cerebral Small Vessel Disease

    NIH RePORTER · NIH RePORTER 11326725 (opens the source filing in a new tab)

  5. Trial

    Study registered

    May 8, 2024

    Multisystemic Smooth Muscle Dysfunction Syndrome, ACTA2 · RECRUITING · sponsor: Massachusetts General Hospital · A Retrospective and Prospective Natural History of Genetic Vasculopathies

    ClinicalTrials.gov · NCT06552052 (opens the source filing in a new tab)

  6. Grant

    R01 · $822k · non-dilutive

    Apr 1, 2023

    UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOULD, DOUGLAS · NINDS · award ends Mar 31, 2028 · Gene therapy for disorders of the extracellular matrix

    NIH RePORTER · NIH RePORTER 10829259 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources